These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 23248098)
1. Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis. Li G; Rivas P; Bedolla R; Thapa D; Reddick RL; Ghosh R; Kumar AP Cancer Prev Res (Phila); 2013 Jan; 6(1):27-39. PubMed ID: 23248098 [TBL] [Abstract][Full Text] [Related]
2. SIRT1 inhibition-induced senescence as a strategy to prevent prostate cancer progression. Huang SB; Rivas P; Yang X; Lai Z; Chen Y; Schadler KL; Hu M; Reddick RL; Ghosh R; Kumar AP Mol Carcinog; 2022 Jul; 61(7):702-716. PubMed ID: 35452563 [TBL] [Abstract][Full Text] [Related]
3. Disruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formation. Powell MJ; Casimiro MC; Cordon-Cardo C; He X; Yeow WS; Wang C; McCue PA; McBurney MW; Pestell RG Cancer Res; 2011 Feb; 71(3):964-75. PubMed ID: 21189328 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation. Lin JN; Lin VC; Rau KM; Shieh PC; Kuo DH; Shieh JC; Chen WJ; Tsai SC; Way TD J Agric Food Chem; 2010 Feb; 58(3):1584-92. PubMed ID: 19928762 [TBL] [Abstract][Full Text] [Related]
5. SIRT1 Regulates the Inflammatory Response of Vascular Adventitial Fibroblasts through Autophagy and Related Signaling Pathway. Wang WR; Li TT; Jing T; Li YX; Yang XF; He YH; Zhang W; Lin R; Zhang JY Cell Physiol Biochem; 2017; 41(2):569-582. PubMed ID: 28214861 [TBL] [Abstract][Full Text] [Related]
6. Sirtuin 1 independent effects of resveratrol in INS-1E β-cells. Erdogan CS; Mørup-Lendal M; Dalgaard LT; Vang O Chem Biol Interact; 2017 Feb; 264():52-60. PubMed ID: 28108221 [TBL] [Abstract][Full Text] [Related]
7. TSC2 N-terminal lysine acetylation status affects to its stability modulating mTORC1 signaling and autophagy. García-Aguilar A; Guillén C; Nellist M; Bartolomé A; Benito M Biochim Biophys Acta; 2016 Nov; 1863(11):2658-2667. PubMed ID: 27542907 [TBL] [Abstract][Full Text] [Related]
8. Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts. Zhu X; Liu Q; Wang M; Liang M; Yang X; Xu X; Zou H; Qiu J PLoS One; 2011; 6(11):e27081. PubMed ID: 22069489 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer. Taniguchi T; Iizumi Y; Watanabe M; Masuda M; Morita M; Aono Y; Toriyama S; Oishi M; Goi W; Sakai T Cell Death Dis; 2016 May; 7(5):e2211. PubMed ID: 27148684 [TBL] [Abstract][Full Text] [Related]
10. The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision. Luchman HA; Benediktsson H; Villemaire ML; Peterson AC; Jirik FR PLoS One; 2008; 3(12):e3940. PubMed ID: 19081794 [TBL] [Abstract][Full Text] [Related]
11. SIRT1 negatively regulates the mammalian target of rapamycin. Ghosh HS; McBurney M; Robbins PD PLoS One; 2010 Feb; 5(2):e9199. PubMed ID: 20169165 [TBL] [Abstract][Full Text] [Related]
12. The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells. Alayev A; Berger SM; Kramer MY; Schwartz NS; Holz MK J Cell Biochem; 2015 Mar; 116(3):450-7. PubMed ID: 25336146 [TBL] [Abstract][Full Text] [Related]
13. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Narayanan NK; Nargi D; Randolph C; Narayanan BA Int J Cancer; 2009 Jul; 125(1):1-8. PubMed ID: 19326431 [TBL] [Abstract][Full Text] [Related]
14. Sirt1 decreased adipose inflammation by interacting with Akt2 and inhibiting mTOR/S6K1 pathway in mice. Liu Z; Gan L; Liu G; Chen Y; Wu T; Feng F; Sun C J Lipid Res; 2016 Aug; 57(8):1373-81. PubMed ID: 27317762 [TBL] [Abstract][Full Text] [Related]
15. Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathway. Zhu X; Chu H; Jiang S; Liu Q; Liu L; Xue Y; Zheng S; Wan W; Qiu J; Wang J; Zou H J Dermatol Sci; 2017 Aug; 87(2):149-158. PubMed ID: 28532580 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol induces vascular smooth muscle cell differentiation through stimulation of SirT1 and AMPK. Thompson AM; Martin KA; Rzucidlo EM PLoS One; 2014; 9(1):e85495. PubMed ID: 24416418 [TBL] [Abstract][Full Text] [Related]
17. Cancer cell survival following DNA damage-mediated premature senescence is regulated by mammalian target of rapamycin (mTOR)-dependent Inhibition of sirtuin 1. Back JH; Rezvani HR; Zhu Y; Guyonnet-Duperat V; Athar M; Ratner D; Kim AL J Biol Chem; 2011 May; 286(21):19100-8. PubMed ID: 21471201 [TBL] [Abstract][Full Text] [Related]
18. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines. Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR. Liu M; Wilk SA; Wang A; Zhou L; Wang RH; Ogawa W; Deng C; Dong LQ; Liu F J Biol Chem; 2010 Nov; 285(47):36387-94. PubMed ID: 20851890 [TBL] [Abstract][Full Text] [Related]
20. Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice. Kladney RD; Cardiff RD; Kwiatkowski DJ; Chiang GG; Weber JD; Arbeit JM; Lu ZH Cancer Res; 2010 Nov; 70(21):8937-47. PubMed ID: 20940396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]